UB Paderborn / Katalog / Suche / in CDI

A Phase 1 Randomized Trial of Specific Active α‐Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy

Movement disorders, 2020-11, Vol.35 (11), p.1957-1965

2020

Link zum Volltext

Verfügbarkeit prüfen

tPA-Like Activity of an Experimental Thrombus in the Presence of Heparin and a Heparin Fraction

Annals of the New York Academy of Sciences, 1989-06, Vol.556 (1), p.435-436

1989

Link zum Volltext

Verfügbarkeit prüfen

Quality of clinical information: a new approach of EQA in Emilia-Romagna, Italy

Annali dell'Istituto superiore di sanità, 1995, Vol.31 (1), p.197-209

1995

Link zum Volltext

Verfügbarkeit prüfen

What is the best plasmatic activity which could be correlated with the antithrombotic effect of heparin and a low molecular weight heparin fragment?

Thrombosis research, 1987-10, Vol.48 (2), p.245-251

1987

Link zum Volltext

Verfügbarkeit prüfen

Quality of clinical information : a new approach of EQA in Emilia-Romagna, Italy: Quality assurance in clinical chemistry and haematology

Annali dell'Istituto superiore di sanità, 1995, Vol.31 (1), p.197-209

1995

Link zum Volltext

Verfügbarkeit prüfen

New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease

Lancet neurology, 2013-08, Vol.12 (8), p.811-821

2013

Link zum Volltext

Verfügbarkeit prüfen

Symptômes neuropsychiatriques et cognition chez des patients avec une maladie de Parkinson débutante

Revue neurologique, 2024-04, Vol.180, p.S18-S18

2024

Link zum Volltext

Verfügbarkeit prüfen

Mood and behavioural effects of subthalamic stimulation in Parkinson's disease

Lancet neurology, 2014-03, Vol.13 (3), p.287-305

2014

Link zum Volltext

Verfügbarkeit prüfen

Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia

Neurology, 2017-09, Vol.89 (13), p.1416

2017

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Long‐Term Outcome of Subthalamic Stimulation in Parkinson Disease

Annals of neurology, 2021-03, Vol.89 (3), p.587-597

2021

Link zum Volltext

Verfügbarkeit prüfen

Fluctuations in Parkinson’s disease and personalized medicine: bridging the gap with the neuropsychiatric fluctuation scale

Frontiers in neurology, 2023-08, Vol.14, p.1242484-1242484

2023

Link zum Volltext

Verfügbarkeit prüfen

The pathogenesis of Pisa syndrome in Parkinson's disease

Movement disorders, 2014-08, Vol.29 (9), p.1100-1107

2014

Link zum Volltext

Verfügbarkeit prüfen

Early limbic microstructural alterations in apathy and depression in de novo Parkinson's disease

Movement disorders, 2019-11, Vol.34 (11), p.1644-1654

2019

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease

Movement disorders, 2014-07, Vol.29 (8), p.1019-1027

2014

Link zum Volltext

Verfügbarkeit prüfen

Emotional manifestations of PD: Neurobiological basis

Movement disorders, 2016-08, Vol.31 (8), p.1103-1113

2016

Link zum Volltext

Verfügbarkeit prüfen

Do neuropsychiatric fluctuations temporally match motor fluctuations in Parkinson’s disease?

Neurological sciences, 2022-06, Vol.43 (6), p.3641-3647

2022

Link zum Volltext

Verfügbarkeit prüfen

Description d’un cas d’atteinte cognitive subaiguë liée à une carence en vitamine B12 secondaire à une intoxication chronique au protoxyde d’azote

Revue neurologique, 2024-04, Vol.180, p.S170-S171

2024

Link zum Volltext

Verfügbarkeit prüfen

A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD

NPJ Parkinson's Disease, 2020-12, Vol.6 (1), p.41-41, Article 41

2020

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal fluid biomarkers in Parkinson disease

Nature reviews. Neurology, 2013-03, Vol.9 (3), p.131

2013

Link zum Volltext

Verfügbarkeit prüfen

Optimizing the risk stratification of astrocytic tumors by applying the cIMPACT-NOW Update 3 signature: real-word single center experience

Scientific reports, 2023-11, Vol.13 (1), p.20101-20101, Article 20101

2023

Link zum Volltext

Verfügbarkeit prüfen

New targets for deep brain stimulation treatment of Parkinson's disease

Expert review of neurotherapeutics, 2013-12, Vol.13 (12), p.1319-1328

2013

Link zum Volltext

Verfügbarkeit prüfen

The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease

Brain (London, England : 1878), 2016-09, Vol.139 (Pt 9), p.2486-2502

2016

Link zum Volltext

Verfügbarkeit prüfen

Iowa gambling task impairment in Parkinson's disease can be normalised by reduction of dopaminergic medication after subthalamic stimulation

Journal of neurology, neurosurgery and psychiatry, 2015-02, Vol.86 (2), p.186-190

2015

Link zum Volltext

Verfügbarkeit prüfen

Imbalanced motivated behaviors according to motor sign asymmetry in drug-naïve Parkinson's disease

Scientific reports, 2023-12, Vol.13 (1), p.21234-21234, Article 21234

2023

Link zum Volltext

Verfügbarkeit prüfen

Disentangling Bradykinesia and Rigidity in Parkinson's Disease: Evidence from Short‐ and Long‐Term Subthalamic Nucleus Deep Brain Stimulation

Annals of neurology, 2024-08, Vol.96 (2), p.234-246

2024

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

A Phase 1 Randomized Trial of Specific Active α‐Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy

tPA-Like Activity of an Experimental Thrombus in the Presence of Heparin and a Heparin Fraction

Quality of clinical information: a new approach of EQA in Emilia-Romagna, Italy

What is the best plasmatic activity which could be correlated with the antithrombotic effect of heparin and a low molecular weight heparin fragment?

Quality of clinical information : a new approach of EQA in Emilia-Romagna, Italy: Quality assurance in clinical chemistry and haematology

New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson's disease

Symptômes neuropsychiatriques et cognition chez des patients avec une maladie de Parkinson débutante

Mood and behavioural effects of subthalamic stimulation in Parkinson's disease

Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia

Predictors of Long‐Term Outcome of Subthalamic Stimulation in Parkinson Disease

Fluctuations in Parkinson’s disease and personalized medicine: bridging the gap with the neuropsychiatric fluctuation scale

The pathogenesis of Pisa syndrome in Parkinson's disease

Early limbic microstructural alterations in apathy and depression in de novo Parkinson's disease

Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease

Emotional manifestations of PD: Neurobiological basis

Do neuropsychiatric fluctuations temporally match motor fluctuations in Parkinson’s disease?

Description d’un cas d’atteinte cognitive subaiguë liée à une carence en vitamine B12 secondaire à une intoxication chronique au protoxyde d’azote

A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD

Cerebrospinal fluid biomarkers in Parkinson disease

Optimizing the risk stratification of astrocytic tumors by applying the cIMPACT-NOW Update 3 signature: real-word single center experience

New targets for deep brain stimulation treatment of Parkinson's disease

The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease

Iowa gambling task impairment in Parkinson's disease can be normalised by reduction of dopaminergic medication after subthalamic stimulation

Imbalanced motivated behaviors according to motor sign asymmetry in drug-naïve Parkinson's disease

Disentangling Bradykinesia and Rigidity in Parkinson's Disease: Evidence from Short‐ and Long‐Term Subthalamic Nucleus Deep Brain Stimulation

Suchergebnisse filtern